pd 173074 has been researched along with Astrocytoma, Grade IV in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
"The effects of the FGFR inhibitor PD173074, the FAK inhibitors PF431396 and Y15 and the αvβ3/αvβ5 integrin inhibitor cilengitide were assessed in L1-positive and L1-negative variants of the human glioblastoma-derived cell lines T98G and U-118 MG." | 3.83 | Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation. ( Anderson, HJ; Galileo, DS, 2016) |
"Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma." | 1.38 | Transforming fusions of FGFR and TACC genes in human glioblastoma. ( Aldape, K; Brat, DJ; Castano, A; Ceccarelli, M; Chan, JM; Finocchiaro, G; Gao, Z; Golfinos, JG; Guha, A; Iavarone, A; Lasorella, A; Liu, EM; Mikkelsen, T; Niola, F; Pellegatta, S; Porrati, P; Qiu, K; Rabadan, R; Reichel, J; Riccardi, R; Singh, D; Sullivan, R; Zagzag, D; Zoppoli, P, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, HJ | 1 |
Galileo, DS | 1 |
Loilome, W | 1 |
Joshi, AD | 1 |
ap Rhys, CM | 1 |
Piccirillo, S | 1 |
Vescovi, AL | 1 |
Angelo, VL | 1 |
Gallia, GL | 1 |
Riggins, GJ | 1 |
Singh, D | 1 |
Chan, JM | 1 |
Zoppoli, P | 1 |
Niola, F | 1 |
Sullivan, R | 1 |
Castano, A | 1 |
Liu, EM | 1 |
Reichel, J | 1 |
Porrati, P | 1 |
Pellegatta, S | 1 |
Qiu, K | 1 |
Gao, Z | 1 |
Ceccarelli, M | 1 |
Riccardi, R | 1 |
Brat, DJ | 1 |
Guha, A | 1 |
Aldape, K | 1 |
Golfinos, JG | 1 |
Zagzag, D | 1 |
Mikkelsen, T | 1 |
Finocchiaro, G | 1 |
Lasorella, A | 1 |
Rabadan, R | 1 |
Iavarone, A | 1 |
3 other studies available for pd 173074 and Astrocytoma, Grade IV
Article | Year |
---|---|
Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.
Topics: Aniline Compounds; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Pro | 2016 |
Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling.
Topics: Antibodies; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzym | 2009 |
Transforming fusions of FGFR and TACC genes in human glioblastoma.
Topics: Aneuploidy; Animals; Antineoplastic Agents; Benzamides; Brain Neoplasms; Cell Transformation, Neopla | 2012 |